Neoral use in the renal transplant recipient
- 15 May 2000
- journal article
- review article
- Published by Elsevier in Transplantation Proceedings
- Vol. 32 (3), S10-S19
- https://doi.org/10.1016/s0041-1345(00)00860-5
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- NEORAL MONITORING BY SIMPLIFIED SPARSE SAMPLING AREA UNDER THE CONCENTRATION-TIME CURVETransplantation, 1999
- Cyclosporine microemulsion increases drug exposure and reduces acute rejection without incremental toxicity in de novo renal transplantationKidney International, 1998
- SAFETY AND TOLERABILITY OF CYCLOSPORINE AND CYCLOSPORINE MICROEMULSION DURING 18 MONTHS OF FOLLOW-UP IN STABLE RENAL TRANSPLANT RECIPIENTSTransplantation, 1998
- Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipientsThe Lancet, 1997
- A MICROEMULSION OF CYCLOSPORINE WITHOUT INTRAVENOUS CYCLOSPORINE IN LIVER TRANSPLANTATION1Transplantation, 1996
- VARIABLE ORAL ABSORPTION OF CYCLOSPORINETransplantation, 1996
- Pharmacokinetic Drug Interactions with Cyclosporin (Part II)Clinical Pharmacokinetics, 1990
- Pharmacokinetic Drug Interactions with Cyclosporin (Part I)1Clinical Pharmacokinetics, 1990
- CyclosporineNew England Journal of Medicine, 1989
- Clinical Pharmacokinetics of CyclosporinClinical Pharmacokinetics, 1986